Government Affairs
Refine Search
Biotechnology
In order to spur research and innovation in the pharmaceutical industry, the Narendra Modi government in India is developing a new policy that will cater to a range of therapies - from gene therapy to precision medicine. 6 February 2023
Pharmaceutical
As the British pharmaceutical industry gets ready to negotiate the reimbursement regime in the country, representatives have expressed dismay at a move to raise the statutory revenue clawback rate. 2 February 2023
Pharmaceutical
The life sciences industry in Australia has called for better funding for the country’s medicine and technology regulator. 31 January 2023
Pharmaceutical
The Belgian pharmaceutical industry has raised concerns around pressures being applied to the national healthcare budget for innovative medicines. 30 January 2023
Generics
The US industry has said that India should come out with a research and development (R&D) policy for its pharmaceutical sector. 30 January 2023
Pharmaceutical
Research from the IQVIA Institute for Human Data Science shows that total spending and global demand for medicines could hit $1.9 trillion by 2027. 27 January 2023
Pharmaceutical
In the context of a sagging economy and a multitude of economic woes, lawmakers in the UK may be receptive to news of the potential for medicines manufacturing to boost growth. 24 January 2023
Pharmaceutical
Russia is facing with a new wave of drugs’ shortages and interruptions of supplies due to the ever-tightening sanctions regime against the country and logistics issues, reports The Pharma Letter’s local correspondent. 23 January 2023
Pharmaceutical
Since 2019, in the Latin American pharma market, imports have doubled the number of exports, writes The Pharma Letter's local correspondent. 20 January 2023
Pharmaceutical
There is no shortage of criticism currently being directed at the UK government from the public sector, especially where healthcare is concerned ... 18 January 2023
Pharmaceutical
In the USA, the National Institute of Allergy and Infectious Diseases (NIAID) has awarded $5.5 million to the Blumberg Institute to research treatments for yellow fever. 18 January 2023
Biotechnology
The European Parliament’s COVI committee has voted to ban officials from US pharma giant Pfizer from attending sessions. 17 January 2023
Pharmaceutical
The trade group representing the UK pharmaceutical industry has published a report highlighting significant variation in access to innovative medicines in the country. 17 January 2023
Generics
India's interim free trade agreement with Australia is set to offer a significant relaxation of factory inspections, which could pave the way for many more commercial deals with developed countries, according to Pharmexcil, India's pharmaceutical export promotion council. 16 January 2023
Pharmaceutical
Large pharmaceutical firms are increasingly upset at the deal they agreed with the British government on drug pricing, the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS). 16 January 2023
Generics
Drug imports to Russia are ongoing almost in the same volumes as in the past, despite the current situation in Russia, according to recent statements by Viktor Dmitriev, general director of the Association of Russian Pharmaceutical Manufacturers (ARPM) and some independent local analysts in the field of pharmaceuticals. 10 January 2023
Biotechnology
One of the pioneers of mRNA technologies, BioNTec, is investing the proceeds of its work during the pandemic on its original focus - cancer vaccines. 6 January 2023
Pharmaceutical
Never has the importance of Flanders’ biopharmaceutical output to the international community been more obvious than it was during the COVID-19 crisis. 3 January 2023
Biotechnology
Faith in the transparency of the US regulatory process has been shaken, following an accusatory report from influential congressional committees into the approval of Aduhelm (aducanumab). 30 December 2022
Generics
A growing number of key starting materials (KSMs) and active pharmaceutical ingredients (APIs) coming into India have become 25% to 35% more expensive as reports of Covid infections spiral out of control in China, squeezing margins and increasing drug prices. The Indian government's production linked incentive (PLI) scheme for the promotion of domestic manufacturing of critical KSMs, drug intermediates (DIs) and APIs is soon set to come to the aid of many domestic players, reports The Pharma Letter’s India correspondent. 29 December 2022
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Pharmaceutical
Trade group the Association of the British Pharmaceutical Industry (ABPI) has had its say on UK government plans to overhaul the National Health Service (NHS). 21 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze